Flow Cytometry Services
Experience customized and validated flow cytometry (FCM) biomarkers and panels for your clinical research on a global scale. Learn how FCM can enhance your research and help develop the panels you need.
Advantages of Flow Cytometry in Immunotherapy Clinical Trials
Complex flow cytometry is critical for today’s personalized medicine. With 25 years of extensive expertise in providing flow cytometry testing for clinical trials ranging from phase I to phase III, Cerba Research has a strong track record of developing and validating custom-made flow cytometry panels. Monitor immunophenotyping, immune cell activation, receptor occupancy of the drug, and the workings of CAR-T cells through flow cytometry on blood samples and bone marrow aspirate.
Our Global Flow Cytometry Network
At Cerba Research, we develop, validate, qualify and implement assays on a global scale. With flow cytometry capacity and capabilities in Belgium, the United States, Australia, China and Taiwan, we are a leading central lab known for our expertise. Our network develops and validates drug-specific panels aligned with your needs. From client conversations to centralized data analysis and review, our global team is dedicated to meeting your target timeline.
Which Flow Cytometry instruments are present in our laboratories worldwide?
- BD FACS Canto: present in laboratories in USA, Belgium, and China
- BD FACS Lyrics: present in laboratories in USA, Belgium, Australia, and Taiwan
- Cytek Aurora in laboratories in USA and Belgium
Assess more than 40 parameters with the Cytek Aurora
With our spectral flow cytometry capabilities, we simultaneously characterize cellular populations from the same tube with a complete set of data from the sample, all while reducing the time of sample acquisition.
Cerba Research is proud to answer your exploratory needs for clinical trials and retrospective analysis with our state of art instruments and high quality data output.